<DOC>
	<DOCNO>NCT00537524</DOCNO>
	<brief_summary>Evaluate immune response reactogenicity H5N1 vaccination subject age 6 month 17 year compare seasonal flu vaccination</brief_summary>
	<brief_title>Immunogenicity , Safety Tolerability Two Doses Pre-pandemic Influenza Vaccine Participants Aged 6 Months 17 Years</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Influenza Birds</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy subject Receipt Seasonal Influenza Vaccine season 2007/2008 Receipt another vaccine within 3 week vaccination Previous vaccination pandemic candidate vaccine and/or vaccine contain adjuvant MF59 similar adjuvant Children local recommendation influenza vaccination due underlying disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Bird flu</keyword>
	<keyword>seasonal influenza vaccine</keyword>
	<keyword>influenza vaccine</keyword>
	<keyword>prepandemic vaccine</keyword>
	<keyword>virus strain potential cause pandemic</keyword>
	<keyword>toddler</keyword>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
</DOC>